Learn more about how Peptide Receptor Radionuclide Therapy (PRRT) can improve care for Neuroendocrine Tumor patients. Another effective illustration of how Radiotheranostics work and its application in the field of oncology.
Watch video >>
Other news & events
- News12.05.2026

#ASCO26 - Radiopharmaceutical Therapy in Oncology: Practical Integration for Practicing Oncologists
Read more - News11.05.2026

Oncidium foundation partners with Curium to expand access to Radioligand Therapy worldwide
Read more - News22.04.2026

Addressing Barriers to Radioligand Therapy at the European Parliament
Read more




